 LEXINGTON, Mass., April 28, 2021 GLOBE NEWSWIRE -- Translate Bio Nasdaq: TBIO, a clinical-stage messenger RNA mRNA therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today announced that Ronald Renaud, chief executive officer, will participate in a fireside chat at the 7th Annual Truist Securities Life Sciences Summit on May 5, 2021 at 10:30 a.m. EST. 